my concern is that they focus on the back end of the transaction, whilst all the competitors are targeting pre and mid transaction. Makes me think we are at the wrong end of it. When you say there is little to no competition, well than ya also wonder is there such a need for our product.
JR touched on the tail end of the transaction not having RegTech competition, but I don’t feel I understood the why/purpose ID8 offers by providing tailend checks.
Did anyone else get the msg about what unique advantage ID8 has by doing back end checks compared to the saturated market of RegTechs doing front end/mid checks?
We were sold a bunch of stuff around $billions 2026, requirements and ISO yadayadayada. We were sold the uniqueness of ID8. But were we sold the why? Why would business want our product? If anyone can answer this than that’s the reason we should continue to invest..
- Forums
- ASX - By Stock
- [VIDEO] ID8 November Investor Briefing
ID8
identitii limited
Add to My Watchlist
0.00%
!
0.6¢

my concern is that they focus on the back end of the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.668M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 12418205 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 27000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 12418205 | 0.005 |
11 | 4526678 | 0.004 |
4 | 1716670 | 0.003 |
2 | 1550000 | 0.002 |
3 | 24600000 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 27000 | 1 |
0.007 | 1292056 | 3 |
0.008 | 1253995 | 1 |
0.009 | 20000 | 1 |
0.010 | 428710 | 1 |
Last trade - 10.45am 04/07/2025 (20 minute delay) ? |
Featured News
ID8 (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online